Reaching people receiving opioid agonist therapy at community pharmacies with hepatitis C virus: an international randomised controlled trial-Reference-Cited by-同舟云学术

Reaching people receiving opioid agonist therapy at community pharmacies with hepatitis C virus: an international randomised controlled trial

Published:2022-05-10 Issue:12 Volume:55 Page:1512-1523
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Byrne Christopher J.¹²^ORCID,Radley Andrew³,Inglis Sarah K.²,Beer Lewis²^ORCID,Palmer Nicki⁴,Duc Pham Minh⁵⁶,Allardice Kate⁶,Wang Huan⁷,Robinson Emma⁸,Hermansson Monika⁹,Semizarov Dimitri⁹,Healy Brendan⁴,Doyle Joseph S.⁵⁶^ORCID,Dillon John F.¹⁸

Affiliation:

1. Division of Molecular and Clinical Medicine School of Medicine Ninewells Hospital and Medical School, University of Dundee Dundee UK

2. Tayside Clinical Trials Unit School of Medicine Ninewells Hospital and Medical School, University of Dundee Dundee UK

3. Directorate of Public Health NHS Tayside Kings Cross Hospital Dundee UK

4. Department of Microbiology and Infectious Diseases Cardiff Public Health Wales Cardiff UK

5. Department of Infectious Diseases The Alfred and Monash University Melbourne Victoria Australia

6. Disease Elimination Program Burnet Institute Melbourne Victoria Australia

7. Division of Population Health and Genomics School of Medicine University of Dundee Dundee UK

8. Department of Gastroenterology NHS Tayside Ninewells Hospital and Medical School Dundee UK

9. AbbVie Ltd AbbVie House Maidenhead UK

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16953

Reference45 articles.

1. Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives

2. How far are we from viral hepatitis elimination service coverage targets?

3. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

4. Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C elimination: amplifying the role of primary care nurses in Australia;Australian Journal of Primary Health;2024-09-12

2. Viral hepatitis testing and treatment in community pharmacies: a systematic review and meta-analysis;eClinicalMedicine;2024-03

3. A multicomponent holistic care pathway for people who use drugs in Tayside, Scotland;International Journal of Drug Policy;2023-10

4. The Urgent Need to Implement Point-of-Care RNA Testing for Hepatitis C Virus to Support Elimination;Clinical Infectious Diseases;2023-08-27

5. The 11th Canadian Symposium on Hepatitis C Virus: ‘Getting back on track towards hepatitis C elimination’;Canadian Liver Journal;2023-02-28